Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $INTS
Intensity Therapeutics Inc.
Subscribe to $INTS
$INTS
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
IPO Year: 2023
Exchange: NASDAQ
Recent Analyst Ratings for Intensity Therapeutics Inc.
Date
Price Target
Rating
Analyst
See more ratings
